Rezolute, Inc.
RZLTNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $403.32M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.07$11.46
- Volume (live)
- -
- Avg. volume (3M)
- 1.72M
Rezolute (RZLT) Stock Price & Financial Analysis
Rezolute Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.67 - $3.97 |
|---|---|
| 52-Week High | $11.46 |
| 52-Week Low | $1.07 |
| Open | $3.67 |
| Volume (last close) | 1.36M |
| Average Volume (3M) | 1.72M |
| 50-Day MA | $4.37 |
|---|---|
| 200-Day MA | $3.82 |
| 1-Year Change | −57.21% |
| Market Cap | 403.32M |
|---|---|
| Shares Outstanding | 104.49M |
| Price to Book (P/B) | 4.01 |
| EV/EBITDA | -5.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Rezolute at a Glance
As of the Oct 22, 2026 close, Rezolute (RZLT) has a market capitalization of $403.32M.
As of its latest reported balance sheet, it holds $10.62M in cash and securities against $934.00K of debt, a net cash position of $9.68M.
Rezolute does not currently pay a dividend.
The share price is down 57.2% over the past year. At $3.86 (the Oct 22, 2026 close) it sits within its 52-week range of $1.07 to $11.46, above its 200-day moving average of $3.82.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.00, 159.1% above the Oct 22, 2026 close.
Frequently Asked Questions About Rezolute
What is the current stock price for RZLT?
As of the Oct 22, 2026 close, RZLT stock trades at $3.86. The 52-week range is $1.07–$11.46, with a day range of $3.67–$3.96.
What is the P/E ratio for RZLT?
The P/E ratio (Price-to-Earnings) for RZLT is shown in the Key Statistics section. This valuation metric helps compare Rezolute, Inc. to industry peers.
Does RZLT pay dividends?
Rezolute does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RZLT?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for RZLT is Buy. The average 12-month price target is $10.00, a 159.1% upside from the Oct 22, 2026 close of $3.86.
What is the market cap of RZLT?
As of the Oct 22, 2026 close, Rezolute's market capitalization is $403.3M, classifying it as a small-cap company. Rezolute operates in the Healthcare sector within the Biotechnology industry.